{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:06:07Z","timestamp":1723939567352},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.2169\/internalmedicine.2990-23","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T22:14:22Z","timestamp":1705097662000},"page":"2307-2310","source":"Crossref","is-referenced-by-count":0,"title":["Use of the Superficialized Brachial Artery as Vascular Access for a Patient with Myasthenia Gravis with a Frequent Need for Plasmapheresis"],"prefix":"10.2169","volume":"63","author":[{"given":"Fumiya","family":"Kitano","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhji","family":"Marui","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Sakurada","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rajasekhar A, Streiff MB. 30 - Use of vena cava filters and venous access devices. In: Consultative Hemostasis and Thrombosis. 4th Ed. Elsevier, Amsterdam, 2019: 594-635.","DOI":"10.1016\/B978-0-323-46202-0.00030-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Santoro D, Benedetto F, Mondello P, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc 7: 281-294, 2014.","DOI":"10.2147\/IJNRD.S46643"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Okafor C, Kalantarinia K. Vascular access considerations for therapeutic apheresis procedures. Semin Dial 25: 140-144, 2012.","DOI":"10.1111\/j.1525-139X.2011.01024.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Motomura M. Recent treatment of myasthenia gravis. Nihon Naika Gakkai Zasshi (J Jpn Soc Inter Med) 104: 1953-1958, 2015.","DOI":"10.2169\/naika.104.1953"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Murai H, Masuda M, Utsugisawa K, et al. Clinical features and treatment status of adult myasthenia gravis in Japan. Clin Exp Neuroimmunol 5: 84-91, 2014.","DOI":"10.1111\/cen3.12091"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Utsugisawa K, Suzuki S, Nagane Y, et al. Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve 50: 493-500, 2014.","DOI":"10.1002\/mus.24213"},{"key":"7","unstructured":"7. Tsugawa J, Tsuboi Y, Inoue S, et al. Long-term outcomes of intermittent immunoadsorption therapy for myasthenia gravis. Rinsho Zasshi Naika (Internal Medicine) 103: 595-598, 2009."},{"key":"8","unstructured":"8. Sakuma K, Utsumi N, Akiyama M, et al. A case of plasma exchange for myasthenia gravis refractory to vascular access. Jin To Toseki (Kidney and Dialysis) 65 (Supplemental Volume Access 2008): 190-192, 2008."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakagawa J, Muramatsu T, Ohta K, et al. A case of refractory myasthenia gravis positive for anti MuSK antibody that was successfully treated with double filtration plasmapheresis. Nihon Toseki Igakkai Zasshi (J Jpn Soc Dial Ther) 40: 531-535, 2007.","DOI":"10.4009\/jsdt.40.531"},{"key":"10","unstructured":"10. Ishikawa T, Siba M, Ikewaki K, et al. A case of long-term LDL apheresis therapy for familial hypercholesterolemia. Prog Med 30: 2699-2707, 2010."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. G\u00fclle S, Bak M, Serdaroglu E, Can D, Karabay O. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia. Ther Apher Dial 14: 87-92, 2010.","DOI":"10.1111\/j.1744-9987.2009.00795.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yasunaga C, Nakamoto M, Fukuda K, Goya T. Superficial repositioning of the artery for chronic hemodialysis: indications and prognosis. Am J Kidney Dis 26: 602-606, 1995.","DOI":"10.1016\/0272-6386(95)90596-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ipe TS, Marques MB. Vascular access for therapeutic plasma exchange. Transfusion 58 (Suppl 1): 580-589, 2018.","DOI":"10.1111\/trf.14479"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kalantari K. The choice of vascular access for therapeutic apheresis. J Clin Apher 27: 153-159, 2012.","DOI":"10.1002\/jca.21225"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wicke C, Halliday B, Allen D, et al. Effects of steroids and retinoids on wound healing. Arch Surg 135: 1265-1270, 2000.","DOI":"10.1001\/archsurg.135.11.1265"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2990-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T03:29:13Z","timestamp":1723865353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2990-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":15,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2990-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"2990-23"}}